Variant report
Variant | esv3377701 |
---|---|
Chromosome Location | chr5:98438309-98438838 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs34246603 | chr5:98438318-98438319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs550589739 | chr5:98438376-98438377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs575416866 | chr5:98438382-98438383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs569919610 | chr5:98438398-98438399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs116010951 | chr5:98438408-98438409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs549159968 | chr5:98438451-98438452 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs567303665 | chr5:98438473-98438474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs73148434 | chr5:98438493-98438494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs553072992 | chr5:98438494-98438495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs577839069 | chr5:98438524-98438525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs538620398 | chr5:98438532-98438533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs556720779 | chr5:98438610-98438611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs540051669 | chr5:98438623-98438624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs575888497 | chr5:98438633-98438634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs558138708 | chr5:98438646-98438647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs561635255 | chr5:98438679-98438680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs573322924 | chr5:98438689-98438690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs573491298 | chr5:98438726-98438727 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs181131599 | chr5:98438744-98438745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs540624695 | chr5:98438756-98438757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs565018087 | chr5:98438782-98438783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs6880487 | chr5:98438818-98438819 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:98438200-98438600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr5:98438600-98441000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |